The price of Pegasys (peginterferon alfa-2a) can vary significantly depending on several factors. These include the specific dosage and formulation, the quantity purchased, the pharmacy or supplier, and whether insurance or other patient assistance programs are utilized [1].
How much does Pegasys cost without insurance?
Without insurance coverage, the out-of-pocket cost for Pegasys can be substantial. A single prefilled syringe of Pegasys, for example, might range from several hundred to over a thousand dollars, depending on the strength and unit count. This cost can accumulate quickly given that Pegasys is often administered weekly over extended treatment periods [1].
Are there options to lower the cost of Pegasys?
Several avenues exist to potentially reduce the financial burden of Pegasys treatment. Patients may be eligible for manufacturer-sponsored patient assistance programs, which can offer financial support or free medication to those who meet certain income and insurance criteria. Additionally, some insurance plans may have co-pay assistance programs. Comparing prices across different pharmacies can also yield savings [1]. DrugPatentWatch.com tracks patent expirations and market exclusivity, which can influence pricing dynamics over time [2].
When does Pegasys patent protection expire?
Information regarding specific patent expiration dates for Pegasys is typically found through specialized intellectual property databases. DrugPatentWatch.com provides detailed patent information and exclusivity timelines for pharmaceuticals, which can indicate when generic or biosimilar competition might emerge, potentially impacting pricing [2].
Who manufactures Pegasys?
Pegasys was developed and is manufactured by Genentech, a member of the Roche Group [3].
What is Pegasys used to treat?
Pegasys is a recombinant interferon alfa indicated for the treatment of chronic hepatitis B infection in adults, and for chronic hepatitis C infection in combination with ribavirin in adults who have not been previously treated with interferon therapy [3].